These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1865548)

  • 1. Monoclonal antibodies to endotoxin. New allies against sepsis?
    Bone RC
    JAMA; 1991 Aug; 266(8):1125-6. PubMed ID: 1865548
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies and the treatment of gram-negative bacteremia and shock.
    Wolff SM
    N Engl J Med; 1991 Feb; 324(7):486-8. PubMed ID: 1988835
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment with monoclonal anti-endotoxin antibodies of patients with sepsis caused by Gram-negative bacteria].
    Ned Tijdschr Geneeskd; 1991 Jul; 135(28):1289-91. PubMed ID: 1861770
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.
    Greenman RL; Schein RM; Martin MA; Wenzel RP; MacIntyre NR; Emmanuel G; Chmel H; Kohler RB; McCarthy M; Plouffe J
    JAMA; 1991 Aug; 266(8):1097-102. PubMed ID: 1865542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody to endotoxin in the treatment of gram-negative sepsis.
    Schentag JJ
    JAMA; 1992 May; 267(17):2326-7. PubMed ID: 1564766
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiendotoxin monoclonal antibodies. What future now?
    Susla GM; Dew RB
    Drug Saf; 1994 Oct; 11(4):215-22. PubMed ID: 7848542
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
    Ziegler EJ; Fisher CJ; Sprung CL; Straube RC; Sadoff JC; Foulke GE; Wortel CH; Fink MP; Dellinger RP; Teng NN
    N Engl J Med; 1991 Feb; 324(7):429-36. PubMed ID: 1988827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers.
    Talan DA
    Ann Emerg Med; 1993 Dec; 22(12):1871-90. PubMed ID: 8239111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to endotoxin in the management of sepsis.
    Fang KC
    West J Med; 1993 Apr; 158(4):393-9. PubMed ID: 8317126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to endotoxin in the treatment of gram-negative sepsis.
    Spalter J
    JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564764
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody to endotoxin in the treatment of gram-negative sepsis.
    McCabe WR
    JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564763
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody to endotoxin in the treatment of gram-negative sepsis.
    van Deventer S
    JAMA; 1992 May; 267(17):2325-6. PubMed ID: 1564765
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological intervention in endotoxin shock.
    Ziegler EJ
    Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-endotoxin monoclonal antibodies in the treatment of gram-negative germ sepsis].
    Baumgartner JD
    Rev Prat; 1991 Jun; 41(16):1479-82. PubMed ID: 1853112
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients.
    Chalfin DB; Holbein ME; Fein AM; Carlon GC
    JAMA; 1993 Jan; 269(2):249-54. PubMed ID: 8417245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal antibodies against endotoxin in septicemia. Marketing or scientific evaluation?].
    Waage A
    Tidsskr Nor Laegeforen; 1994 Mar; 114(8):951-3. PubMed ID: 8191476
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current developments in the field of infection caused by gram-negative microorganisms; passive immunization using anti-endotoxin antibodies].
    van Deventer SJ; ten Cate JW; Appelmelk BJ
    Ned Tijdschr Geneeskd; 1987 Oct; 131(43):1907-10. PubMed ID: 3317073
    [No Abstract]   [Full Text] [Related]  

  • 18. Life-saving immunotherapy with cross-reactive monoclonal antibodies against endotoxin: a critical evaluation of experimental and clinical studies.
    Cornelissen JJ; Schellekens JF; Kraaijeveld CA; Verhoef J
    Neth J Med; 1991 Oct; 39(3-4):170-6. PubMed ID: 1791879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxin antibody for sepsis in infants.
    Nadel S; Klein N; Heyderman R; Levin M
    Lancet; 1992 Mar; 339(8794):678. PubMed ID: 1347362
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis.
    Dunn DL; Bogard WC; Cerra FB
    Surgery; 1985 Aug; 98(2):283-90. PubMed ID: 3895540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.